|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hill A, Fisher P and Yeomanson D:
Non-small cell lung cancer. BMJ. 345:e64432012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cykert S, Dilworth-Anderson P, Monroe MH,
Walker P, McGuire FR, Corbie-Smith G, Edwards LJ and Bunton AJ:
Factors associated with decisions to undergo surgery among patients
with newly diagnosed early-stage lung cancer. JAMA. 303:2368–2376.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fervers B: Chemotherapy in elderly
patients with resected stage II–IIIA lung cancer. BMJ.
343:d41042011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sullivan R, Alatise OI, Anderson BO,
Audisio R, Autier P, Aggarwal A, Balch C, Brennan MF, Dare A,
D'Cruz A, et al: Global cancer surgery: Delivering safe,
affordable, and timely cancer surgery. Lancet Oncol. 16:1193–1224.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Global Burden of Disease Cancer
Collaboration, Fitzmaurice C, . Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The Global burden of cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
National Lung Screening Trial Research
Team, . Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan
F, Fagerstrom RM, Gareen IF, Gierada DS, et al: Results of initial
low-dose computed tomographic screening for lung cancer. N Engl J
Med. 368:1980–1991. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gasparini P, Cascione L, Landi L, Carasi
S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, et
al: microRNA classifiers are powerful diagnostic/prognostic tools
in ALK-, EGFR-, and KRAS-driven lung cancers. Proc Natl Acad Sci
USA. 112:pp. 14924–14929. 2015, View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng CJ, Bahal R, Babar IA, Pincus Z,
Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM,
et al: MicroRNA silencing for cancer therapy targeted to the tumour
microenvironment. Nature. 518:107–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martello G, Rosato A, Ferrari F, Manfrin
A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T,
et al: A MicroRNA targeting dicer for metastasis control. Cell.
141:1195–1207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar C, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou W, Fong MY, Min Y, Somlo G, Liu L,
Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al:
Cancer-secreted miR-105 destroys vascular endothelial barriers to
promote metastasis. Cancer Cell. 25:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hood JL, San RS and Wickline SA: Exosomes
released by melanoma cells prepare sentinel lymph nodes for tumor
metastasis. Cancer Res. 71:3792–3801. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guan Y, Chen L, Bao Y, Li Z, Cui R, Li G
and Wang Y: Identification of low miR-105 expression as a novel
poor prognostic predictor for human glioma. Int J Clin Exp Med.
8:10855–10864. 2015.PubMed/NCBI
|
|
17
|
NCBI Resource Coordinators: Database
resources of the national center for biotechnology information.
Nucleic Acids Res. 44:D7–D19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:(Database Issue).
D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lantuejoul S, Rouquette I, Brambilla E and
Travis WD: New WHO classification of lung adenocarcinoma and
preneoplasia. Ann Pathol. 36:5–14. 2016.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB and Compton CC: The American Joint
Committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schaap-Oziemlak AM, Raymakers RA,
Bergevoet SM, Gilissen C, Jansen BJ, Adema GJ, Kögler G, le Sage C,
Agami R, van der Reijden BA and Jansen JH: MicroRNA hsa-miR-135b
regulates mineralization in osteogenic differentiation of human
unrestricted somatic stem cells. Stem Cells Dev. 19:877–885. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao B, Zhu Y, Cui K, Gao J, Yu F, Chen L
and Li S: Expression and significance of PTEN and miR-92 in
hepatocellular carcinoma. Mol Med Rep. 7:1413–1416. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao F, Wang T, Zhang Z, Wang R, Guo Y and
Liu J: Regulation of activating protein-4-associated metastases of
non-small cell lung cancer cells by miR-144. Tumour Biol. Aug
8–2015.(Epub ahead of print).
|
|
26
|
Qi F, He T, Jia L, Song N, Guo L, Ma X,
Wang C, Xu M, Fu Y, Li L and Luo Y: The miR-30 family inhibits
pulmonary vascular hyperpermeability in the premetastatic phase by
direct targeting of Skp2. Clin Cancer Res. 21:3071–3080. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu
Y, Chen Y, Xu L, Zen K, Zhang C and Shen H: Serum microRNA
signatures identified in a genome-wide serum microRNA expression
profiling predict survival of non-small-cell lung cancer. J Clin
Oncol. 28:1721–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu D, Hu X, Zhou H, Shi G and Wu J:
Identification of aberrantly expressed miRNAs in gastric cancer.
Gastroenterol Res Pract. 2014:4738172014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zen K and Zhang CY: Circulating microRNAs:
A novel class of biomarkers to diagnose and monitor human cancers.
Med Res Rev. 32:326–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen G, Rong X, Zhao J, Yang X, Li H,
Jiang H, Zhou Q, Ji T, Huang S, Zhang J and Jia H: MicroRNA-105
suppresses cell proliferation and inhibits PI3K/AKT signaling in
human hepatocellular carcinoma. Carcinogenesis. 35:2748–2755. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han Y, Jia C, Cong X, Yu F, Cai H, Fang S,
Cai L, Yang H, Sun Y, Li D, et al: Increased expression of TGFβR2
is associated with the clinical outcome of non-small cell lung
cancer patients treated with chemotherapy. PLoS One.
10:e01346822015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Honeywell DR, Cabrita MA, Zhao H,
Dimitroulakos J and Addison CL: miR-105 inhibits prostate tumour
growth by suppressing CDK6 levels. PLoS One. 8:e705152013.
View Article : Google Scholar : PubMed/NCBI
|
